Why is my HDL low when everything else is normal? Because the panel that produced those numbers was looking at the wrong signal. Low HDL alongside an unremarkable LDL and triglycerides is, in our clinic, the single most common first visible mark of insulin resistance. High fasting insulin shifts liver metabolism in a way that lowers HDL and produces small dense LDL particles and the shift runs years ahead of any blood sugar change, which is why the annual panel keeps saying normal while the one number that moved keeps being ignored. The answer is to measure the metabolic state the HDL is marking rather than to chase the HDL itself.
- Low HDL with normal LDL is most often the earliest visible sign of insulin resistance rather than a standalone problem.
- Fasting insulin explains most of these cases and is the marker standard panels most often omit.
- HDL is a risk marker rather than a treatment target. Raising it pharmacologically failed to reduce events in outcome trials.
- ApoB on the same draw catches the small dense particle picture the standard LDL number hides.
- The Biomarker Audit reads insulin, ApoB, HbA1c, hs-CRP and the full lipid panel every 90 days.
What HDL actually is andwhat it is not
HDL particles carry cholesterol out of tissues and back to the liver, a process called reverse cholesterol transport andpopulation studies found higher HDL tracking with lower cardiac risk. The causal story turned out to be more complicated than the correlation. Genetic studies of people with lifelong high HDL show no correspondingly lower risk of heart attack andthe pharmacologic trials that raised HDL substantially, most famously with niacin and CETP inhibitors, failed to reduce cardiovascular events despite moving the number. The 2019 ACC/AHA guideline reflects that history, treating HDL as part of the risk discussion rather than a target to medicate.
So the low HDL is not itself the danger. It is the messenger. And the message is usually about insulin.
The insulin resistance mechanism, in one paragraph
When tissues stop responding to insulin, the pancreas compensates by producing more andfasting insulin climbs years before glucose does. Chronically elevated insulin drives the liver to export more very-low-density lipoprotein particles, which lowers HDL through enzymatic remodeling and produces LDL particles that are smaller and denser than standard. The standard lipid panel reports the cholesterol mass inside those particles, which can look reassuring, while the particle count, which the artery actually responds to, climbs. The result is a patient whose HDL reads low, whose LDL reads normal and whose actual atherogenic burden is rising. This is why ApoB belongs on the same draw as the insulin andwhy a lipid panel without an insulin line is an incomplete risk picture.
The panel that explains a low HDL
When a patient presents with isolated low HDL, these are the markers that do the explaining andthey fit on one draw.
- Fasting insulin. The earliest moving marker of insulin resistance and the direct answer to the mechanism above. It is also the marker most likely to be absent from your previous panels.
- HbA1c. Confirms where the ninety day glucose average sits and gives the reversal conversation its baseline.
- ApoB. Counts the particles. Catches the small dense picture the LDL mass hides andresponds to intervention within weeks, which makes it the best progress marker in the set.
- hs-CRP. The inflammation signal that travels with insulin resistance and adds independent cardiovascular information.
- TSH with reflex to free T4. Thyroid dysfunction lowers HDL too anda thyroid in range but not right is a common co-conspirator in the normal-looking panel that keeps getting repeated.
Our Biomarker Audit reads all of these every 90 days, alongside Lp(a) drawn for lifetime risk, a full lipid panel, a comprehensive metabolic panel and a CBC. The quarterly cadence is not ceremonial. Insulin, triglycerides and ApoB respond to intervention within weeks to months, so a quarterly read shows whether the protocol is moving the markers that matter while the levers are still being pulled.


What actually raises HDL, honestly
The interventions that reliably move HDL are the ones that reverse insulin resistance. Aerobic exercise raises it modestly and reliably. Losing visceral fat raises it, often substantially andGLP-1 therapy has a role where weight is a driver and criteria are met, prescribed branded and FDA-approved only. Reducing refined carbohydrate intake raises it, because refined carbs are what pushed the liver toward the particle pattern in the first place. Quitting smoking raises it within weeks. What does not work is niacin or any HDL-raising drug as an event-prevention strategy, because the trials failed andthe honest framing is that HDL is a marker to improve by fixing the metabolism underneath it rather than a number to medicate upward.
Who this article is for
The person with the low HDL and the normal everything else is usually either the Stability-Seeking patient whose annual panel has been repeated unexamined for years or the High-Deductible System Skipper who has been paying cash for labs that omit the one marker that would explain the finding. Both deserve the same complete draw andboth deserve a clinician who reads the markers as one system. If your HDL has been called slightly low at every physical for a decade while nobody ever drew a fasting insulin, the missing marker was the point.
The membership that includes it is one flat $299 per month covering the clinician and four audits a year, with a single $598 first charge covering the first two months together, held at sign-up and charged only once a clinician accepts you into care. Medication is billed by the pharmacy at its own price with zero markup. The eligibility check is free, takes a few minutes and never results in a charge unless a clinician accepts you into care.
Frequently Asked Questions
Why is my HDL low when everything else is normal?
Low HDL alongside normal LDL and triglycerides is most often the first visible mark of insulin resistance. High fasting insulin shifts liver metabolism toward small dense LDL particles and lower HDL and the shift can appear years before blood sugar moves. A panel with fasting insulin and ApoB usually explains what the standard lipid panel left unclear.
Does low HDL alone raise heart attack risk?
Less than once believed. Large genetic studies show that raising HDL pharmacologically does not reduce events and the current guidance treats HDL as a risk marker rather than a treatment target. What matters is the particle burden, measured by ApoB and the metabolic state HDL is marking.
How do I raise my HDL naturally?
The levers that reliably move it are aerobic exercise, losing visceral fat, quitting smoking and reducing refined carbohydrate intake. Niacin and HDL-raising drugs failed in outcome trials and are not recommended for this purpose.
What labs explain a low HDL?
The useful set is fasting insulin, HbA1c, ApoB, triglycerides, TSH and hs-CRP. Together they distinguish the insulin resistance pattern from thyroid causes and from the small dense particle picture the standard panel cannot see.
Is low HDL a sign of prediabetes?
It can be. Low HDL with high triglycerides is part of the metabolic syndrome definition and either finding alongside a rising fasting insulin or waist circumference suggests the prediabetic window is open, the state where reversal is cheapest.
Does the GoodLife Health membership include these markers?
Yes. The Biomarker Audit reads ApoB, Lp(a), hs-CRP, HbA1c, fasting insulin, a full lipid panel, a comprehensive metabolic panel, a CBC and TSH with reflex to free T4 every 90 days, inside the flat $299 monthly membership.
How often should these markers be rechecked?
Every 90 days when the picture is being worked. Insulin, triglycerides and ApoB respond to intervention within weeks to months, so a quarterly cadence shows whether the protocol is moving the right markers.
What does the membership cost?
One flat $299 per month covering the clinician and four Biomarker Audits a year, with a single $598 first charge covering the first two months together. From month three it is month to month and you can cancel anytime. Medication is billed separately by the pharmacy at cost.
One last thing
The low HDL that gets waved off at every annual physical for a decade is usually the first line of a story the panel was never built to read. The line that would have explained it, the fasting insulin, costs a few dollars on the same draw and sits outside the standard order. The gap between those two facts is most of what our membership exists to close, one flat fee for the doctor and zero markup on the medicine, with the full panel drawn four times a year so the early signals stop arriving unaccompanied.
Related Guides
- Cardiometabolic Optimization: the definitive guide
- ApoB vs LDL cholesterol: which number predicts heart attack risk?
- What a Biomarker Audit includes
- How much does an insulin resistance test cost?
References
- Arnett DK et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease, Circulation, 2019. doi.org/10.1161/CIR.0000000000000678
- Ference BA et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease, European Heart Journal, 2017. doi.org/10.1093/eurheartj/ehx144
- CDC, cholesterol testing resources. cdc.gov